Biocon Appoints Shreehas Tambe as New MD & CEO; Siddharth Mittal Moves to Group Role

• Shreehas Tambe will take over as the new CEO and MD of Biocon Ltd. starting April 1, 2026.
• Siddharth Mittal resigns as CEO and MD, effective March 31, 2026, to transition into another leadership role within the Biocon Group.
• Kedar Upadhye has been appointed as the chief financial officer of Biocon.
• This leadership change is part of the full integration of Biocon Biologics Ltd. as a wholly-owned subsidiary, simplifying the corporate structure.
• Biocon shares declined 2.4% following the announcement.